GlaxoSmithKline Warned about Misleading Marketing in 2001
The Food and Drug Administration warned GlaxoSmithKline in 2001 that it needed to halt playing down the risk of heart attacks connected with taking Avandia, according to a Bloomberg News article ("U.S. FDA Warned Glaxo in 2001 About Avandia Marketing," May 24, 2007).
According to this report, a diabetes expert submitted a letter to the FDA a year earlier, airing concerns about Glaxo's perceived abuse of clinical trial data in regard to the cardiovascular safety of Avandia.
Following this warning, says Bloomberg, the FDA sent Glaxo a letter asking that its marketers stop denying or minimizing the increased risk of heart attacks and other cardiovascular events.
However, the article says, "Glaxo didn't notify doctors or patients of the possible increase in risks."
If you or a loved one has suffered cardiac complications after taking Avandia, you need the guidance of an experienced drug attorney. Get a free case review by filling out the form below.
Dallas Lawsuit Avandia Lawsuit Filed in Dallas Federal Court Against GlaxoSmithKline
Dallas Man Dies of Heart Attack the Day News Breaks of Avandia Risks
Secret Avandia Vote Secret FDA Avandia Vote Outrages Senator--Begs Questions on Procedure
Secret FDA Avandia Panel Voted by Thin Margin to Keep Drug on Market
2010 update Avandia Settlements | Weitz & Luxenberg Taking Cardiac Risk Cases
Discuss possible Avandia lawsuit settlements with our attorneys if you suffered heart problems after taking this diabetes drug. Get a free case review